scholarly journals Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”

ACS Nano ◽  
2021 ◽  
Author(s):  
Jianqin Lu ◽  
Xiangsheng Liu ◽  
Yu-Pei Liao ◽  
Xiang Wang ◽  
Ayman Ahmed ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Immunogenic Cell Death ◽  
Liposomal Delivery

scholarly journals Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway

ACS Nano ◽  
2018 ◽  
Vol 12 (11) ◽  
pp. 11041-11061 ◽  
Author(s):  
Jianqin Lu ◽  
Xiangsheng Liu ◽  
Yu-Pei Liao ◽  
Xiang Wang ◽  
Ayman Ahmed ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Immunogenic Cell Death ◽  
Liposomal Delivery

scholarly journals Laser nanobubbles induce immunogenic cell death in breast cancer

Nanoscale ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 3644-3653
Author(s):  
Hieu T. M. Nguyen ◽  
Nitesh Katta ◽  
Jessica A. Widman ◽  
Eri Takematsu ◽  
Xu Feng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Dendritic Cell ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Cell Activation ◽  
Immunogenic Cell Death ◽  
Dendritic Cell Activation

Laser nanobubbles induce dendritic cell activation in breast cancer cells.

scholarly journals Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances

Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1128
Author(s):  
Amy Kwan ◽  
Natalie Winder ◽  
Munitta Muthana
Keyword(s):  
Breast Cancer ◽  
Clinical Trials ◽  
Cell Death ◽  
Immune System ◽  
Menopausal Status ◽  
Oncolytic Virotherapy ◽  
Immunogenic Cell Death ◽  
Tumour Type ◽  
Common Cancer ◽  
Direct Cell

Oncolytic virotherapy (OV) is an emerging class of immunotherapeutic drugs. Their mechanism of action is two-fold: direct cell lysis and unmasking of the cancer through immunogenic cell death, which allows the immune system to recognize and eradicate tumours. Breast cancer is the most common cancer in women and is challenging to treat with immunotherapy modalities because it is classically an immunogenically “cold” tumour type. This provides an attractive niche for OV, given viruses have been shown to turn “cold” tumours “hot,” thereby opening a plethora of treatment opportunities. There has been a number of pre-clinical attempts to explore the use of OV in breast cancer; however, these have not led to any meaningful clinical trials. This review considers both the potential and the barriers to OV in breast cancer, namely, the limitations of monotherapy and the scope for combination therapy, improving viral delivery and challenges specific to the breast cancer population (e.g., tumour subtype, menopausal status, age).

scholarly journals Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum‐Targeting Copper(II) Complex

ChemBioChem ◽  
2020 ◽  
Vol 21 (24) ◽  
pp. 3618-3624 ◽  
Author(s):  
Pooja Kaur ◽  
Alice Johnson ◽  
Joshua Northcote‐Smith ◽  
Chunxin Lu ◽  
Kogularamanan Suntharalingam
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Endoplasmic Reticulum ◽  
Cell Death ◽  
Cancer Stem Cells ◽  
Immunogenic Cell Death ◽  
Breast Cancer Stem Cells ◽  
Endoplasmic Reticulum Targeting
Sign in / Sign up

Export Citation Format

Share Document